NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)
Funding Amount
Not stated
Deadline
Forecast — expected June 1, 2027
Forecast by the agency; not yet open
Number of Awards
30
Grant Type
Federal
Deadline history & next window
- Cycle
- Not stated
- Next expected
- June 1, 2027
- Tracked since
- July 2026
Forecast: expected to post April 30, 2027; applications expected due June 1, 2027.
Source: Grants.gov forecast for this opportunity.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Nonprofits (501(c)(3))
- Tribal organizations
- For-profit businesses
- Nonprofits without 501(c)(3) status
- Tribal governments
- City & township governments
- Private colleges & universities
- Special district governments
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Overview
This Notice of Funding Opportunity (NOFO) invites applications for NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional). These Core Centers are part of an integrated program of biomedical and translational research supporting our cystic fibrosis, diabetes, nutrition, obesity, liver and digestive diseases research. They enhance multidisciplinary collaboration, rigor, reproducibility, replication and research cost efficiencies at institutions that already have a large established research base in one of the above focused areas within NIDDK’s mission. They should also provide a rich mentoring environment for trainees and early-stage investigators. The P30 Centers accomplish their purpose by providing a Pilot and Feasibility Grant Program, a Scientific Catalyst Program, and importantly shared access to the services of Cores. Within a given P30 Center, the Scientific Catalyst Program, which works within the Administrative Core, supports activities that strengthen the Center’s scientific community and advance its research mission. Activities may include research team building, investigator mentoring, seminars, workshops, visiting scientists, and scientific research series. The program is intended to foster multidisciplinary collaboration, attract new investigators, and engage investigators with expertise relevant to the Center’s chronic disease research focus. The Core Services reflect the research needs of the Center and may include research consultation along with services involving cell or other models, planning, analysis, hands-on services, access to expensive specialized equipment, other technical resources or training shared by the Center members and operated or overseen by recognized experts.
Full eligibility text
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
Focus Areas & Funding Uses
Fields of Work
- Health
Related Grants
Open grants from this funder and similar programs
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional). Now let's win it.